Autism Approval: Medical Marijuana

Autism Approval: Medical Marijuana

SAN DIEGO, Feb. 28, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).


This marks the first time Brazil’s National Health Surveillance Agency ANVISA has granted a prescription for RSHO™ to help an autism patient. Earlier this month, Medical Marijuana, Inc. also announced that ANVISA had also granted the filling of two separate prescriptions for RSHO™ for the first time to help a patient combat the effects of Multiple Sclerosis and Alzheimer’s disease.


“We commend the Brazilian government for its compassionate approach to cannabis and for recognizing the need for alternative treatments to treat medical conditions for which there are currently no cure,” said Chief Executive Officer of Medical Marijuana, Inc., Dr. Stuart Titus. “We hope that this most recent decision by ANVISA will bring light to additional families in Brazil who have children with autism that could benefit from access to our hemp oil. We’re optimistic about several new studies being conducted on the potential benefits of cannabis on individuals with autism, including one study being conducted in Israel focusing on CBD’s effects on behavioral symptoms associated with autism.”


ASD is a neurodevelopment disorder that develops in infancy or childhood and is characterized by social interaction difficulties, verbal and physical communication impairments, and restricted and repetitive patterns of behavior. According to the Centers for Disease Control and Prevention, 1 in 68 children in the U.S. currently have ASD. In Brazil, recent statistics suggest that 1.5 million total children have autism.


Hoping to further bring the benefits to more people suffering from autism, Mexican neurosurgeon, Dr. Saul Garza has recently mentioned that he is currently enrolling patients for a study on the effects of CBD on autism. This study comes after Dr. Garza concluded a research study on Lennox-Gastaut epilepsy in Mexico with favorable results for the botanical CBD version that is allowed into Mexico (HempMeds® RSHO-X™). These results are set to be published in the near future and formally presented at the International Epilepsy Congress in Barcelona, Spain, Sept. 2-6, 2017.


About HempMeds Brasil™

HempMeds Brasil™ currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson’s and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds Brasil is working on additional approvals for multiple indications.


About Medical Marijuana, Inc.


Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit


To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


5 comments to Autism Approval: Medical Marijuana

  • that is pretty interesting. what is it used to help with in ASD? All about new advances in medicine and learning. with having a little with ASD I am always looking for new info, although he isn’t medicated. Just curious.
    Stephanie recently posted..How to style a shirt dress with jeans.

  • I would definitely want more studies as to how cannabinoids can actually affect and manage a person’s autism condition. One thing is for sure- if this is eventually approved for use for autism, I don’t think it should be given to young children- save this medication for adults over 18 with autism. even as an oil, cannabinoids are still active as a psychoactive substance, and I’m not sure you would want young children to experience that affect.

  • Hi Tammy! This is another great news. Sad to say, some other countries are still not open to Medicinal Marijuana. It is surprising to know Brazil having 1.5 million of children with autism. It’s a pretty big number. It is a good decision for Brazil to recognize Medicinal Marijuana.

  • Thank you for sharing this. There has been a lot of research on marijuana’s effect on ASD, and more and more is coming out. It would be great if more and more countries came to an agreement about it.

  • Aaron C.

    With Marijuana being approved for autism. It should also be approved for depression, anxiety, and more. Thanks for writing!

Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

CommentLuv badge


This blog accepts forms of cash advertising,paid guest posts, sponsorship, paid insertions or other forms of compensation. This blog uses affiliate links within posts.